Liver Cancer Immunity

ανά Rizvi, Sumera, Wang, Juan, El-Khoueiry, Anthony B.
Τόπος έκδοσης Hepatology (2020)

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

ανά Hack, Stephen P., Verret, Wendy, Mulla, Sohail, Liu, Bo, Wang, Yulei, Macarulla, Teresa, Ren, Zhenggang, El-Khoueiry, Anthony B., Zhu, Andrew X.
Τόπος έκδοσης Ther Adv Med Oncol (2021)

Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma

ανά Zhou, Kali, Pickering, Trevor A, Gainey, Christina S, Cockburn, Myles, Stern, Mariana C, Liu, Lihua, Unger, Jennifer B, El-Khoueiry, Anthony B, Terrault, Norah A
Τόπος έκδοσης JNCI Cancer Spectr (2020)

Monitoring Twitter Conversations for Targeted Recruitment in Cancer Trials in Los Angeles County: Protocol for a Mixed-Methods Pilot Study

ανά Reuter, Katja, Angyan, Praveen, Le, NamQuyen, MacLennan, Alicia, Cole, Sarah, Bluthenthal, Ricky N, Lane, Christianne J, El-Khoueiry, Anthony B, Buchanan, Thomas A
Τόπος έκδοσης JMIR Res Protoc (2018)

SWOG 0514: A phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma

ανά El-Khoueiry, Anthony B., Rankin, Cathryn J., Ben-Josef, Edgar, Lenz, Heinz-Josef, Gold, Philip J., Hamilton, R. Darryl, Govindarajan, Rangaswamy, Eng, Cathy, Blanke, Charles D.
Έκδοση 2011

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202

ανά Iqbal, Syma, Rankin, Cathryn, Lenz, Heinz-Josef, Gold, Philip J., Ahmad, Syed A., El-Khoueiry, Anthony B., Messino, Michael J., Holcombe, Randall F., Blanke, Charles D.
Έκδοση 2011

Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancer

ανά El‑Khoueiry, Anthony B., Sarantopoulos, John, O’Bryant, Cindy L., Ciombor, Kristen K., Xu, Huiping, O’Gorman, Melissa, Chakrabarti, Jayeta, Usari, Tiziana, El-Rayes, Bassel F.
Τόπος έκδοσης Cancer Chemother Pharmacol (2018)

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

ανά King, Gentry T., Eaton, Keith D., Beagle, Brandon R., Zopf, Christopher J., Wong, Gilbert Y., Krupka, Heike I., Hua, Steven Y., Messersmith, Wells A., El-Khoueiry, Anthony B.
Τόπος έκδοσης Invest New Drugs (2018)

A Phase I Trial of Escalating Doses of Cixutumumab (IMC- A12) and Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma

ανά El-Khoueiry, Anthony B., O’Donnell, Robert, Semrad, Thomas J., Mack, Philip, Blanchard, Suzette, Bahary, Nathan, Jiang, Yixing, Yen, Yun, Wright, John, Chen, Helen, Lenz, Heinz-Josef, Gandara, David R.
Τόπος έκδοσης Cancer Chemother Pharmacol (2018)

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours

ανά Aung, Kyaw L., El-Khoueiry, Anthony B., Gelmon, Karen, Tran, Ben, Bajaj, Gaurav, He, Bing, Chen, Tian, Zhu, Lili, Poojary, Sharath, Basak, Shashwati, Qi, Zhenhao, Spreafico, Anna, Fischer, Bruce S., Desai, Jayesh
Τόπος έκδοσης Invest New Drugs (2018)

A Phase I Study of Intravenous Fenretinide (4-HPR) for Patients with Malignant Solid Tumors

ανά Thomas, Jacob S., El-Khoueiry, Anthony B., Maurer, Barry J., Groshen, Susan, Pinski, Jacek K., Cobos, Everardo, Gandara, David R., Lenz, Heinz J., Kang, Min H, Reynolds, C. Patrick, Newman, Edward M.
Τόπος έκδοσης Cancer Chemother Pharmacol (2021)

Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer (GC) patients after surgery with curative intent

ανά Wakatsuki, Takeru, Stintzing, Sebastian, Zhang, Wu, Yang, Dongyun, Azuma, Mizutomo, Ning, Yan, Yamauchi, Shinichi, Matsusaka, Satoshi, Volz, Nico B., Sunakawa, Yu, Koizumi, Wasaburo, Watanabe, Masahiko, Barzi, Afsaneh, El Khoueiry, Anthony B, Shah, Manish A, Lenz, Heinz-Josef
Έκδοση 2014

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fuoro-2′-deoxycytidine, administered with tetrahydrouridine

ανά Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Τόπος έκδοσης Cancer Chemother Pharmacol (2015)

Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

ανά Kim, Richard D., McDonough, Shannon, El-Khoueiry, Anthony B., Bekaii-Saab, Tanios S., Stein, Stacey M., Sahai, Vaibhav, Keogh, George P., Kim, Edward J., Baron, Ari D., Siegel, Abby B., Barzi, Afsaneh, Guthrie, Katherine A., Javle, Milind, Hochster, Howard
Τόπος έκδοσης Eur J Cancer (2020)

Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma

ανά Siegel, Abby B., El-Khoueiry, Anthony B., Finn, Richard S., Guthrie, Katherine A., Goyal, Abhishek, Venook, Alan P., Blanke, Charles D., Verna, Elizabeth C., Dove, Lorna, Emond, Jean, Kato, Tomoaki, Samstein, Benjamin, Busuttil, Ronald, Remotti, Helen, Coffey, Amy, Brown Jr, Robert S.
Τόπος έκδοσης Liver Cancer (2015)

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbla...

ανά Ben-Josef, Edgar, Guthrie, Katherine A., El-Khoueiry, Anthony B., Corless, Christopher L., Zalupski, Mark M., Lowy, Andrew M., Thomas, Charles R., Alberts, Steven R., Dawson, Laura A., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B., Blanke, Charles D.
Τόπος έκδοσης J Clin Oncol (2015)

Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma

ανά Kelley, Robin Kate, Meyer, Tim, Rimassa, Lorenza, Merle, Philippe, Park, Joong-Won, Yau, Thomas, Chan, Stephen L., Blanc, Jean-Frederic, Tam, Vincent C., Tran, Albert, Dadduzio, Vincenzo, Markby, David W., Kaldate, Rajesh, Cheng, Ann-Lii, El-Khoueiry, Anthony B., Abou-Alfa, Ghassan K.
Τόπος έκδοσης Clin Cancer Res (2020)

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

ανά Kelley, Robin Kate, Ryoo, Baek-Yeol, Merle, Philippe, Park, Joong-Won, Bolondi, Luigi, Chan, Stephen L, Lim, Ho Yeong, Baron, Ari D, Parnis, Francis, Knox, Jennifer, Cattan, Stéphane, Yau, Thomas, Lougheed, Julie C, Milwee, Steven, El-Khoueiry, Anthony B, Cheng, Ann-Lii, Meyer, Tim, Abou-Alfa, Ghassan K
Τόπος έκδοσης ESMO Open (2020)

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

ανά El-Khoueiry, Anthony B, Sangro, Bruno, Yau, Thomas, Crocenzi, Todd S, Kudo, Masatoshi, Hsu, Chiun, Kim, Tae-You, Choo, Su-Pin, Trojan, Jörg, Welling, Theodore H, Meyer, Tim, Kang, Yoon-Koo, Yeo, Winnie, Chopra, Akhil, Anderson, Jeffrey, Cruz, Christine dela, Lang, Lixin, Neely, Jaclyn, Tang, Hao, Dastani, Homa B, Melero, Ignacio
Τόπος έκδοσης Lancet (2017)

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial

ανά Yau, Thomas, Kang, Yoon-Koo, Kim, Tae-You, El-Khoueiry, Anthony B., Santoro, Armando, Sangro, Bruno, Melero, Ignacio, Kudo, Masatoshi, Hou, Ming-Mo, Matilla, Ana, Tovoli, Francesco, Knox, Jennifer J., Ruth He, Aiwu, El-Rayes, Bassel F., Acosta-Rivera, Mirelis, Lim, Ho-Yeong, Neely, Jaclyn, Shen, Yun, Wisniewski, Tami, Anderson, Jeffrey, Hsu, Chiun
Τόπος έκδοσης JAMA Oncol (2020)